Identification of Predictive Biomarkers of Mood Relapses in Patients With Bipolar Disorder

NCT ID: NCT04703972

Last Updated: 2021-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-13

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Relapses in bipolar disorders are associated with a significant proportional functional impact, as well as worsening of the course of bipolar disorder, with impairment of the quality of functional remission, as well as the development of addictive, anxiety and suicidal comorbidities.The functional deficit and the instability of the mood disorder increase with thymic relapses. Currently, these relapses (transition from the state of remission, to a depressive or hyperthymic state) are difficult to predict and to treat because of the absence of correlation between the degree of severity of the stressful event (intensity associated stress) and the occurrence of relapse, taking into account the mediation of this relationship by the stress compensation / adaptation capacities, which are very individual.

This project proposes to develop tools based on artificial intelligence technologies to monitor the level of stress and adaptation to life events as well as identifying relapse predictive factors of a patient by using portable and connected devices recording different physiological signals in order to alert him/her when there is a risk of relapse, thus anticipating therapeutic strategies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bipolar Patients with connected devices

Patients with bipolar disorder provided with connected devices (wristwatch and wristband)

Group Type EXPERIMENTAL

clinical assessment (mood relapses identification)

Intervention Type BEHAVIORAL

clinical assessment via psychometric scales physiological data acquired automatically via the connected device (wristwatch, wristband)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

clinical assessment (mood relapses identification)

clinical assessment via psychometric scales physiological data acquired automatically via the connected device (wristwatch, wristband)

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

physiological data monitoring

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Voluntary subjects responding to the diagnosis of bipolar I or II disorder according to the criteria of the DSM-5
* Agreement to benefit from connected objects required for study and able to understand their use
* Age between 18 and75 years old
* Affiliated to the Social Security system (beneficiary or entitled)
* No opposition signed

Exclusion Criteria

* Subject included in clinical and/or therapeutic experimentation with exclusion period
* Primary psychiatric pathology other than bipolar type I or II disorder
* Patient hospitalized without consent
* Subject deprived of liberty by judicial or administrative decision
* Pregnant, parturient, breastfeeding woman
* Known allergy to one of the materials of the bracelets
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Commissariat A L'energie Atomique

OTHER_GOV

Sponsor Role collaborator

University Hospital, Grenoble

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mircea POLOSAN, MD-PhD

Role: CONTACT

04 76 76 54 11

Arnaud Pouchon, MD

Role: CONTACT

04 76 76 54 11

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

38RC20.087

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neurofeedback for Bipolar Disorder
NCT05802446 RECRUITING NA